Skip to main content

Evotec SE

EVOTF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001412558

No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesEVO

Superinvestors holding EVOTF, Q2 2026

See all superinvestors

No superinvestor reported holding EVOTF in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of EVOTF each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2022

    0 superinvestors holding at quarter end

    Sold out
    ARK Invest
  2. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−4.5%)
  3. Q1 2022

    1 superinvestor holding at quarter end

    New
    ARK Invest